BETWEENOption Agreement • February 11th, 2000 • Diversa Corp • Services-commercial physical & biological research • Delaware
by and amongStockholders' Agreement • February 9th, 2000 • Diversa Corp • Services-commercial physical & biological research • New York
LEASE KILROY REALTYLease • May 12th, 2000 • Diversa Corp • Services-commercial physical & biological research • California
OF RECOMBINANT BIOCATALYSIS, INC.Diversa Corp • December 16th, 1999
BC INTERNATIONAL CORPORATION INDEMNIFICATION AGREEMENTIndemnification Agreement • March 19th, 2007 • Diversa Corp • Services-commercial physical & biological research • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of December 20, 2004 between BC INTERNATIONAL, INC., a Delaware corporation (the “Company”), and Joshua Ruch (“Indemnitee”).
BETWEENDiversa Corp • August 14th, 2000 • Services-commercial physical & biological research • Delaware
BETWEENLicense Agreement • August 14th, 2000 • Diversa Corp • Services-commercial physical & biological research • Delaware
VERENIUM CORPORATION and , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OFWarrant Agreement • November 15th, 2007 • Verenium Corp • Services-commercial physical & biological research • New York
COMMON STOCK WARRANT AGREEMENT (“WARRANT AGREEMENT”), dated as of , between VERENIUM CORPORATION, a Delaware corporation (the “COMPANY”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “WARRANT AGENT”).
NEW VENTURE LLC ARTICLE 9 OF THIS LIMITED LIABILITY COMPANY AGREEMENT LIMITS THE TRANSFER OR HYPOTHECATION OF THE INTERESTS REPRESENTED HEREBY (THE "INTERESTS"). THE INTERESTS REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF...Limited Liability Company Agreement • August 14th, 2000 • Diversa Corp • Services-commercial physical & biological research • Delaware
Confidential Treatment Requested Under 17 C.F.R. (S)(S) 200.80(b)(4) 200.83 and 230.406 LICENSE AGREEMENT This Agreement is made as of the 29/th/ day of March, 1999 by and between Invitrogen Corporation, a corporation organized and existing under the...License Agreement • February 9th, 2000 • Diversa Corp • Services-commercial physical & biological research • California
EXHIBIT 10.10 THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT RELATED...Warrant Agreement • December 16th, 1999 • Diversa Corp • Illinois
Confidential Treatment Requested Under 17 C.F.R. (S)(S) 200.80(b)(4) 200.83 and 230.406 Addendum to the "COLLABORATION AGREEMENT" between Novartis Agribusiness Biotechnology Research, Inc. and Diversa Corporation. This addendum dated and effective as...Stock Purchase Agreement • February 9th, 2000 • Diversa Corp • Services-commercial physical & biological research • California
VERENIUM CORPORATION and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OFWarrant Agreement • November 15th, 2007 • Verenium Corp • Services-commercial physical & biological research • New York
DEBT SECURITIES WARRANT AGREEMENT (“WARRANT AGREEMENT”), dated as of , between VERENIUM CORPORATION, a Delaware corporation (the “COMPANY”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “WARRANT AGENT”).
ARTICLE 1 DEFINITIONSLicense Agreement • February 9th, 2000 • Diversa Corp • Services-commercial physical & biological research • New York
AndCollaboration Agreement • March 30th, 2001 • Diversa Corp • Services-commercial physical & biological research • England
EXHIBIT 10.13 MULTI-TENANT OFFICE R & D BUILDING LEASE - MODIFIED GROSS This Lease between Sycamore/San Diego Investors, an Illinois Limited Partnership ("Landlord"), and Recombinant BioCatalysis, Inc., a Delaware Corporation ("Tenant"), is dated...Diversa Corp • December 16th, 1999
Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 240.24b-2. BP License Agreement Schedule 1.17 - Trade SecretsVerenium Corp • May 13th, 2011 • Industrial organic chemicals
EXHIBIT 10.22 SECOND AMENDMENT The License Agreement ("Agreement") between Mycogen Corporation ("MYCOGEN") and Diversa Corporation ("DIVERSA"), dated December 19, 1997, was amended on March 6, 1998 ("March 6/th/ Amendment"). In order to avoid possible...License Agreement • February 9th, 2000 • Diversa Corp • Services-commercial physical & biological research • California
EXHIBIT 1.1 ____________ Shares of Common Stock Diversa Corporation UNDERWRITING AGREEMENT ----------------------Underwriting Agreement • January 20th, 2000 • Diversa Corp • Services-commercial physical & biological research • New York
EXHIBIT 10.21 LICENSE AGREEMENT This Agreement is made as of the 29/th/ day of March, 1999 by and between Invitrogen Corporation, a corporation organized and existing under the laws of the State of Delaware, with principal offices located at 1600...License Agreement • December 16th, 1999 • Diversa Corp
LOAN AND SECURITY AGREEMENTLoan and Security Agreement • March 5th, 2012 • Verenium Corp • Industrial organic chemicals • California
This LOAN AND SECURITY AGREEMENT (this “Agreement”) is entered into as of October 19, 2011, by and between COMERICA BANK (“Bank”) and VERENIUM CORPORATION (“Borrower”).
VERENIUM LICENSE ***Text Omitted and Filed Separately SCHEDULE 1.10 - with the Securities and Exchange Commission. Confidential EXTENDED TERM Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) PATENT RIGHTS and 240.24b-2.License Agreement • May 13th, 2011 • Verenium Corp • Industrial organic chemicals
ARTICLE TITLE PAGE ------------------------------------------------------------ -------------------------------------------------------- 1 Definitions 2 ------ -------------------------------------------------------------------------------...Project Agreement • March 30th, 2001 • Diversa Corp • Services-commercial physical & biological research
ARTICLE TITLE PAGE NUMBER ----------------------------------------------------- ---------------------------------------------- 1 DEFINITIONS 1 ---------------- ------------------------------------------------------------------------------- ---- 2 R&D...Collaborative Research Agreement • February 11th, 2000 • Diversa Corp • Services-commercial physical & biological research • Delaware
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 25th, 2008 • Verenium Corp • Services-commercial physical & biological research • New York
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 22, 2008, by and among Verenium Corporation, a Delaware corporation, with its principal executive office located at 55 Cambridge Parkway, Cambridge, MA 02142 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
Confidential Treatment Requested Under 17 C.F.R. (S)(S) 200.80(b)(4) 200.83 and 230.406 COLLABORATION AGREEMENT This Collaboration Agreement (the "Agreement") entered into as of June 28, 1999 (the "Effective Date"), is by and between Rhone-Poulenc...Collaboration Agreement • February 9th, 2000 • Diversa Corp • Services-commercial physical & biological research • New York
EXHIBIT 10.19 STOCK PURCHASE AGREEMENT Dated as of January 25, 1999 by and between DIVERSA CORPORATIONStock Purchase Agreement • December 16th, 1999 • Diversa Corp • California
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 8th, 2008 • Verenium Corp • Services-commercial physical & biological research • New York
• transactions where broker-dealers may agree with the selling securityholders to sell a specified number of such shares at a stipulated price per share;
Diversa Corporation REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 28th, 2007 • Diversa Corp • Services-commercial physical & biological research • New York
THIS REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made and entered into as of March 28, 2007, by and among Diversa Corporation, a Delaware corporation (the “Company”), and UBS Securities LLC and the other Initial Purchasers named in the Purchase Agreement referred to below (collectively, the “Initial Purchasers”) pursuant to that certain Purchase Agreement, dated March 22, 2007 (the “Purchase Agreement”), among the Company and the Initial Purchasers.
ARTICLE 1 DEFINITIONSPatent Cross-License Agreement • February 9th, 2000 • Diversa Corp • Services-commercial physical & biological research • California
RecitalsIndemnity Agreement • December 16th, 1999 • Diversa Corp • Delaware
September 24, 2008 Mr. Carlos A. Riva Hamilton, MA 01936 Dear Carlos:Verenium Corp • November 10th, 2008 • Industrial organic chemicals • Massachusetts
We are pleased to confirm the continued compensation and employment agreement between you and Verenium Corporation (the “Company”). In consideration of the covenants and agreements set forth below, the Company hereby continues to employ you, and you hereby agree to be employed by the Company, on the following terms and conditions:
andRights Agreement • December 15th, 2000 • Diversa Corp • Services-commercial physical & biological research • Delaware
CREDIT AGREEMENT Dated as of December 7, 2012 among VERENIUM CORPORATION as the Borrower, THE DOMESTIC SUBSIDIARIES OF THE BORROWER, as the Guarantors, ATHYRIUM OPPORTUNITIES FUND (A) LP, as Administrative Agent and a Lender and THE OTHER LENDERS FROM...Credit Agreement • April 1st, 2013 • Verenium Corp • Industrial organic chemicals • New York
This CREDIT AGREEMENT is entered into as of December 7, 2012 among VERENIUM CORPORATION, a Delaware corporation (the “Borrower”), the Guarantors (defined herein), the Lenders (defined herein) and ATHYRIUM OPPORTUNITIES FUND (A) LP, as Administrative Agent.
STOCK OPTION AGREEMENT Pursuant to the Grant Notice and this Stock Option Agreement, the Company has granted you an option to purchase the number of shares of the Company's common stock ("Common Stock") indicated in the Grant Notice at the exercise...Stock Option Agreement • December 16th, 1999 • Diversa Corp
